Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate their translation into clinical use. The NCITA consortium and collaborators aim to improve clinical outcomes for patients through early cancer identification and new treatment discoveries.

Original publication

DOI

10.32907/RO-128-2267290092

Type

Other

Publisher

Research Outreach

Publication Date

02/02/2022

Addresses

Martina McAteer, University of Oxford, Department of Oncology, Oxford, Oxfordshire, OX3 7DQ, United Kingdom

Keywords

Cancer imaging, NCITA infrastructure, oncology